Methylphenidate reduces orienting bias in healthy individuals
Leehe Peled-Avron1, Hagar Gelbard Goren1, Noa Brande-Eilat1
1Department of Psychology, University of Haifa, Haifa, Israel.
Journal of Psychopharmacology (Oxford, England)
|March 15, 2021
Summary
Methylphenidate (MPH) reduces spatial orienting bias in healthy individuals, normalizing attention asymmetry. This suggests MPH has an asymmetric neural effect in the healthy brain, impacting dopamine signaling.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Psychopharmacology
Background:
- Healthy individuals exhibit pseudoneglect, an orienting bias towards one hemispace.
- This bias is an individual trait linked to hemispheric dopamine signaling.
- Methylphenidate (MPH) normalizes spatial attention bias in patients, suggesting asymmetric dopamine modulation.
Purpose of the Study:
- To investigate if MPH reduces orienting bias in healthy subjects.
- To test the hypothesis that MPH normalizes spatial attention bias in healthy individuals.
Main Methods:
- A randomized, double-blind, placebo-controlled, within-subject study.
- 36 healthy participants received a single 20mg dose of MPH.
- The greyscales task was used to measure behavioral effects on orienting bias.
Main Results:
- Healthy subjects display variable spatial orienting bias.
- MPH administration significantly reduced the magnitude of this orienting bias.
- The effect was observed regardless of the initial direction of bias.
Conclusions:
- MPH decreases spatial orienting bias in healthy subjects asymmetrically.
- Findings suggest MPH may have asymmetric neural effects in the healthy brain.
- This supports the link between orienting bias, dopamine signaling, and MPH action.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
535
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
535
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
299
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
299
02:07Blind Procedures
12.5K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.5K
01:27Halo Effect
142
The halo effect is a cognitive bias in which an individual's overall impression influences judgments about their specific traits. This psychological phenomenon leads people to associate positive characteristics with those they perceive as generally good and negative characteristics with those they view as bad. This effect is particularly influential in social perception, professional evaluations, and decision-making processes.The Psychological Basis of the Halo EffectThe halo effect is rooted...
142
01:25Adrenergic Agonists: Indirect-Acting Agents
2.3K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.3K